[HTML][HTML] Rapamycin interferes with postdepletion regulatory T cell homeostasis and enhances DSA formation corrected by CTLA4-Ig
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
[HTML][HTML] Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig
B Oh, J Yoon, A Farris, A Kirk, S Knechtle… - American Journal of …, 2016 - amjtransplant.org
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig
B Oh, J Yoon, A Farris, A Kirk… - American Journal of …, 2016 - pure.johnshopkins.edu
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
[PDF][PDF] Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig
B Oh, J Yoon, AF III, A Kirk, S Knechtle… - American Journal of …, 2016 - academia.edu
The immunosuppressive effect of rapamycin, an mTOR inhibitor, is mainly explained by the
drug's interference with dendritic cell (DC) maturation/function, T cell proliferation, and …
drug's interference with dendritic cell (DC) maturation/function, T cell proliferation, and …
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig
B Oh, J Yoon, A Farris 3rd, A Kirk… - … : official journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4‐Ig
B Oh, J Yoon, A Farris III, A Kirk… - American Journal of …, 2016 - Wiley Online Library
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig.
B Oh, J Yoon, A Farris 3rd, A Kirk… - American Journal of …, 2016 - europepmc.org
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig.
B Oh, J Yoon, A Farris, A Kirk, S Knechtle, J Kwun - 2016 - dukespace.lib.duke.edu
Previously, we demonstrated that alemtuzumab induction with rapamycin as sole
maintenance therapy is associated with an increased incidence of humoral rejection in …
maintenance therapy is associated with an increased incidence of humoral rejection in …